That cell specialization…it’s pretty important.
(From our video)
Cryptosporidium is a microscopic parasite that causes the diarrhoeal disease cryptosporidiosis. Both the parasite and the disease are commonly known as “Crypto.”
The parasite is protected by an outer shell (oocyst)
Allows survival outside the body for long periods of time
Very tolerant to chlorine disinfection.
Water is the most common form of spread
Poses serious risk to immunocompromised individuals, eg AIDS; cancer and transplant patients who are taking certain immunosuppressive drugs.
Symptoms of cryptosporidiosis generally begin 2 to 10 days (average 7 days) after infection.
Watery diarrhea
Stomach cramps or pain
Dehydration
Nausea
Vomiting
Fever
Weight loss
Some people with Crypto will have no symptoms at all.
Symptoms usually last about 1 to 2 weeks (with a range of a few days to 4 or more weeks) in persons with healthy immune systems. Occasionally, people may experience a recurrence of symptoms after a brief period of recovery before the illness ends. Symptoms can come and go for up to 30 days.
In immunocompromised persons Cryptosporidium infections could possibly affect other areas of the digestive tract or the respiratory tract.
Cryptosporidium oocysts in a modified acid-fast stain. (CDC Photo; DPDx)
Examination of stool samples.
Detection can be difficult - several stool samples over several days.
acid-fast staining, direct fluorescent antibody [DFA] , and/or enzyme immunoassays
Molecular methods (e.g., polymerase chain reaction – PCR) are increasingly used in reference diagnostic labs,
Most people who have healthy immune systems will recover without treatment. Young children and pregnant women may be more susceptible to dehydration resulting from diarrhoea.
For those persons with AIDS, anti-retroviral therapy (improves the immune status) will also decrease or eliminate symptoms of cryptosporidiosis. However, even if symptoms disappear, cryptosporidiosis is often not curable and the symptoms may return if the immune status worsens.
Advanced immunosuppression — typically CD4 T lymphocyte cell (CD4) counts of <100 cells/µL — is associated with the greatest risk for prolonged, severe, or extraintestinal cryptosporidiosis.
The three species that most commonly infect humans are Cryptosporidium hominis, Cryptosporidium parvum, and Cryptosporidium meleagridis. Infections are usually caused by one species, but a mixed infection is possible.
Up to 74% of diarrhoea stools in AIDS patients demonstrating the organism in less developed countries where potent antiretroviral therapy is not widely available,
cryptosporidiosis has decreased and occurs at an incidence of <1 case per 1000 person-years in patients with AIDS.4 Infection occurs through ingestion of Cryptosporidium oocysts. Viable oocysts in feces can be transmitted directly through contact with infected humans or animals, particularly those with diarrhea. Oocysts can contaminate recreational water sources such as swimming pools and lakes, and public water supplies and may persist despite standard chlorination (see Appendix: Food and Water-Related Exposures). Person-to-person transmission is common, especially among sexually active men who have sex with men.
Fever is present in approximately one-third of patients and malabsorption is common.
The epithelium of the biliary tract and the pancreatic duct can be infected with Cryptosporidium, leading to sclerosing cholangitis and to pancreatitis secondary to papillary stenosis,
Pulmonary infections also have been reported, and may be under-recognized.
ART with immune restoration to a CD4 count >100 cells/µL usually leads to resolution
Treatment of diarrhoea with anti-motility agents (AIII) may be necessary.
Patients with biliary tract involvement may require endoscopic retrograde choledocoduodenoscopy for diagnosis.
Immune reconstitution inflammatory syndrome (IRIS) has not been described in association with treatment of cryptosporidiosis.
No pharmacologic interventions are known to be effective in preventing the recurrence of cryptosporidiosis.
No therapy has been shown to be effective without ART.
Happy flu season! I’ve just been stuck inside for 5 days with a mild case, so this is a bit bitter
There are 3–5 million cases of flu per year, and ~375,000 deaths, usually in older, younger, and immunocompromised individuals.
Enveloped, Single-stranded RNA virus
First identified in 1933, but existed long before
Generally considered an infection of the bronchi
so effectively a form of bronchitis – i.e. it causes inflammation of the bronchi
There are 3 types - A, B and C
B & C appear restricted to humans
C is less common
A is found in wide range of species including pigs and poultry as well as man
Type A appears to be responsible for more severe disease
Transmission by aerosols
Incubation ~2 days
Contagious during first 3-5days of illness
Symptoms – fever, myalgia, headache, dry cough, sore throat, aches, fatigue
Recovery ~7-10 days for most
Complications – most frequent = secondary bacterial pneumonia, rarely = viral pneumonia, myocarditis, encephalitis
No specific treatment
Vaccination for high risk groups including the elderly, health care workers, those with underlying respiratory conditions.
The main reservoir is wildfowl that are resistant to the disease
doesn’t usually affect animals other than poultry and pigs
However some transfer events occur
Incidence highest in winter
Strains vary from year to year - hard to predict and vaccinate (this year’s vaccine has been pretty rubbish)
Can be caused by any strain that has not been seen in the human population for many years
New strains evade the herd immunity that exists to previously encountered strains
1918 /19 –( Spanish) estimated 40-50 million deaths worldwide
1957 – Influenza A/H1N1 (Asian)
1968 – Influenza A/H3N2 (Hong Kong)
Eventually the virus runs out of susceptible hosts and the epidemic fizzles out
Experts generally agree another pandemic is inevitable, and may be imminent – maybe we have had some minor pandemics
16000 confirmed H1N1 deaths in 2009 affecting over 200 countries
Consensus is that the prompt action of the Hong Kong authorities probably prevented a pandemic in 1997
The prediction is scary - for industrialised countries they predic 1.0 – 2.3 million hospitalisations
280,000-650,000 deaths
in two years
A network of 112 centres monitor flu isolates to identify unusual strains that can then be examined further
The WHO has a Pandemic Preparedness Plan in place http://www.who.int/influenza/preparedness/pandemic/en/
Generally based on GP diagnosis
Virus isolation / virus demonstration from nasopharyngeal secretions during acute phase
Demonstration of viral antigen in secretions
Antibody rise using paired sera ( 1st sample taken between days 1-3 of illness, 2nd taken around day 12 of illness) by haemagglutination inhibition or complement fixation test
Molecular methods evolving rapidly – in particular in response to the recent epidemic/pandemic strains emerging
A range of respiratory illnesses have the same symptoms, only laboratory testing can confirm the aetiological agent
In the UK NICE argue that immunisation against predicted strains is the best form of defence – traditionally focused on the elderly and those with underlying lung problems, but recently started rolling out a childhood vaccine (nasal spray)
Vaccines generally based on the H & N surface structures which mutate, however hopes of an M protein based vaccine which will give longer lasting protection raised recently
Antivirals
Antivirals not recommended in otherwise healthy people (amantadine should not be used at all) - should ride it out
However when incidence reaches a certain level zanamivir and oseltamivir should be used in those considered high risk for the development of complications – PROVIDED THAT TREATMENT IS STARTED WITHIN 48 HOURS OF ONSET OF SYMPTOMS
Resistance is becoming an issue
-28/11/17-
Had cramps so spent the day writing up microbiology notes whilst hunched over my hot water bottle. The lecture on vaccine design is 7 pages long and now I can hand cramp to my list of ailments…
Gram+, anaerobe, spore forming, motile, rod.
Neurotoxin: Tetanus Toxin blocks glycine and GABA and produces a SPASTIC PARALYSIS.
TETANUS
Opisthotonus
Risus Sardonicus
Severe mucle spasm
Who wants a box of chocolates when you can have a petri dish of bacteria?
It’s Medical Mnemonics Monday!
Renal Papillary Necrosis is a form of nephropathy characterized by coagulative necrosis of the renal medullary pyramids and papillae.
Causes of Papillary Necrosis can be remembered by the mnemonic “POSTCARDS”.
P yelonephritis
O bstruction of the urogenital tract
S ickle cell disease
T uberculosis
Chronic liver disease,
A nalgesia /A lcohol abuse,
R enal transplant rejection
D iabetes mellitus
S ystemic vasculitis
Check out the list of the previous Medical Mnemonics here.
05-11-18 bio notes! i tried out a new background and i think it looks really pretty!! i hope you guys like it :). i had my first test for my dissection lab and my group ended up getting 100%! the next few tests are harder, but i think we’ll all do gr8. i hope you all had a great week!
Archaeans are single-celled and join bacteria to make up the Prokaryotes. The Archaea classification is a very recent discovery, due to the similarities in appearance and behaviour to bacteria they weren’t separated until the late 1970′s. They mostly live in extreme environments and can be sub grouped:
Methanogens - produce methane gas as a waste product of their “digestion,” or process of making energy.
Halophiles - live in salty environments.
Thermophiles - live at extremely hot temperatures.
Psychrophiles — those that live at unusually cold temperatures.
Like bacteria, archaea lack a true nucleus. Both bacteria and archaea usually have one DNA molecule suspended in the cell’s cytoplasm contained within a cell membrane. Most, but not all, have a tough, rigid outer cell wall.
use a variety of substances for energy, including hydrogen gas, carbon dioxide and sulfur.
many archaea thrive in conditions mimicking those found more than 3.5 billion years ago. [eg oceans that regularly reached boiling point — an extreme condition not unlike the hydrothermal vents and sulfuric waters where archaea are found today]